Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Immunotherapy. This report contains market size and forecasts of Oncolytic Virus Immunotherapy in global, including the following market information:
Global Oncolytic Virus Immunotherapy Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Oncolytic Virus Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
We surveyed the Oncolytic Virus Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncolytic Virus Immunotherapy Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Global Oncolytic Virus Immunotherapy Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Oncolytic Virus Immunotherapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncolytic Virus Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncolytic Virus Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncolytic Virus Immunotherapy, market overview.
Chapter 2: Global Oncolytic Virus Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Oncolytic Virus Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncolytic Virus Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Immunotherapy Overall Market Size
2.1 Global Oncolytic Virus Immunotherapy Market Size: 2022 VS 2035
2.2 Global Oncolytic Virus Immunotherapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Immunotherapy Players in Global Market
3.2 Top Global Oncolytic Virus Immunotherapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncolytic Virus Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncolytic Virus Immunotherapy Market Size Markets, 2022 & 2035
4.1.2 Engineering Oncolytic Viruses
4.1.3 Wild-Type Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
4.2.3 By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Immunotherapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
5.2.3 By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Immunotherapy Market Size, 2022 & 2035
6.2 By Region - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
6.2.3 By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.3.2 US Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.3.3 Canada Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.3.4 Mexico Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.4.2 Germany Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.3 France Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.4 U.K. Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.5 Italy Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.6 Russia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.7 Nordic Countries Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.8 Benelux Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.5.2 China Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.3 Japan Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.4 South Korea Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.5 Southeast Asia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.6 India Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.6.2 Brazil Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.6.3 Argentina Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.7.2 Turkey Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.3 Israel Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.4 Saudi Arabia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.5 UAE Oncolytic Virus Immunotherapy Market Size, 2018-2035
7 Oncolytic Virus Immunotherapy Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Oncolytic Virus Immunotherapy Major Product Offerings
7.1.4 Merck Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncolytic Virus Immunotherapy Major Product Offerings
7.2.4 Amgen Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 TILT Biotherapeutics
7.3.1 TILT Biotherapeutics Company Summary
7.3.2 TILT Biotherapeutics Business Overview
7.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.3.4 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 TILT Biotherapeutics Key News & Latest Developments
7.4 Oncorus
7.4.1 Oncorus Company Summary
7.4.2 Oncorus Business Overview
7.4.3 Oncorus Oncolytic Virus Immunotherapy Major Product Offerings
7.4.4 Oncorus Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Oncorus Key News & Latest Developments
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Company Summary
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.5.4 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Sorrento Therapeutics Key News & Latest Developments
7.6 Shanghai Sunway Biotech
7.6.1 Shanghai Sunway Biotech Company Summary
7.6.2 Shanghai Sunway Biotech Business Overview
7.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Major Product Offerings
7.6.4 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 Shanghai Sunway Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncolytic Virus Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Immunotherapy Market Drivers in Global Market
Table 3. Oncolytic Virus Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Immunotherapy in Global Market
Table 5. Top Oncolytic Virus Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncolytic Virus Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncolytic Virus Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncolytic Virus Immunotherapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 30. Merck Company Summary
Table 31. Merck Oncolytic Virus Immunotherapy Product Offerings
Table 32. Merck Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Oncolytic Virus Immunotherapy Product Offerings
Table 36. Amgen Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. TILT Biotherapeutics Company Summary
Table 39. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 40. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. TILT Biotherapeutics Key News & Latest Developments
Table 42. Oncorus Company Summary
Table 43. Oncorus Oncolytic Virus Immunotherapy Product Offerings
Table 44. Oncorus Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Oncorus Key News & Latest Developments
Table 46. Sorrento Therapeutics Company Summary
Table 47. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 48. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Sorrento Therapeutics Key News & Latest Developments
Table 50. Shanghai Sunway Biotech Company Summary
Table 51. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offerings
Table 52. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Shanghai Sunway Biotech Key News & Latest Developments
List of Figures
Figure 1. Oncolytic Virus Immunotherapy Segment by Type in 2022
Figure 2. Oncolytic Virus Immunotherapy Segment by Application in 2022
Figure 3. Global Oncolytic Virus Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Immunotherapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Oncolytic Virus Immunotherapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2022
Figure 8. By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 16. US Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 20. Germany Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 28. China Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 34. Brazil Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 37. Turkey Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 41. Merck Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Oncorus Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
